{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:56Z","timestamp":1793946476494,"version":"4.8.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005310","name":"Tel Aviv University Claire and Am\u00e9d\u00e9e Maratier Institute for the Study of Blindness and Visual Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.exer.2026.111284","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:08:32Z","timestamp":1791414512000},"page":"111284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel laboratory technique for immunofluorescent detection of intraocular ranibizumab in a rat model"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-906X","authenticated-orcid":false,"given":"Assaf","family":"Ben-Arzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5487-5723","authenticated-orcid":false,"given":"Itay","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-4295","authenticated-orcid":false,"given":"Yariv","family":"Keshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-4555","authenticated-orcid":false,"given":"Orly","family":"Gal-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-0717","authenticated-orcid":false,"given":"Irit","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-2048","authenticated-orcid":false,"given":"Assaf","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111284_bib1","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.exer.2026.111284_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1044-5323(03)00047-2","article-title":"Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules","volume":"15","author":"Barclay","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.exer.2026.111284_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.66.6.1","article-title":"Anti-VEGF agents clearance through the aqueous outflow pathway in a rat model","volume":"66","author":"Ben-Arzi","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111284_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7462098","article-title":"Sustained intraocular pressure rise after the treat and extend regimen at 3 years: aflibercept versus ranibizumab","volume":"2020","author":"Bilgic","year":"2020","journal-title":"J. Ophthalmol"},{"key":"10.1016\/j.exer.2026.111284_bib5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2165\/00003495-200767080-00007","article-title":"Ranibizumab","volume":"67","author":"Blick","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.exer.2026.111284_bib6","first-page":"309","article-title":"The immunoglobulin fold. Structural classification, sequence patterns and common core","volume":"242","author":"Bork","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.exer.2026.111284_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/eye.2015.217","article-title":"Ranibizumab for the treatment of wet AMD: a summary of real-world studies","volume":"30","author":"Chong","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2026.111284_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, for the treatment of neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.exer.2026.111284_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archophthalmol.2010.297","article-title":"Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections","volume":"128","author":"Frenkel","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111284_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.exer.2016.02.006","article-title":"Bevacizumab clearance through the iridocorneal angle following intravitreal injection in a rat model","volume":"145","author":"Gal-Or","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111284_bib11","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.exer.2026.111284_bib12","series-title":"Immunobiology: the Immune System in Health and Disease","article-title":"The structure of a typical antibody molecule","author":"Janeway","year":"2001"},{"key":"10.1016\/j.exer.2026.111284_bib13","first-page":"5204","article-title":"Principle and techniques of immunohistochemistry \u2013 a review","volume":"6","author":"Kabiraj","year":"2015","journal-title":"Int. J. Biol. Med. Res."},{"key":"10.1016\/j.exer.2026.111284_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/002215540104900509","article-title":"A new rapid immunohistochemical staining technique using the EnVision antibody complex","volume":"49","author":"K\u00e4mmerer","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.exer.2026.111284_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40942-021-00322-8","article-title":"Aflibercept clearance through the drainage system in a rat model","volume":"7","author":"Keshet","year":"2021","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.exer.2026.111284_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12195-020-00641-0","article-title":"Structure-guided molecular engineering of a vascular endothelial growth factor antagonist to treat retinal diseases","volume":"13","author":"Kureshi","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.exer.2026.111284_bib17","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.0914318107","article-title":"Structural determinants of growth factor binding and specificity by VEGF receptor 2","volume":"107","author":"Lepp\u00e4nen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.exer.2026.111284_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2026.111284_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234739","article-title":"Real-world outcomes with ranibizumab in branch retinal vein occlusion: the prospective, global, LUMINOUS study","volume":"15","author":"Pearce","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2026.111284_bib20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2026.111284_bib21","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"3","author":"Solomon","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.exer.2026.111284_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exer.2026.111284_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0092-8674(00)80456-0","article-title":"Crystal structure at 1.7 \u00c5 resolution of VEGF in complex with domain 2 of the Flt-1 receptor","volume":"91","author":"Wiesmann","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.exer.2026.111284_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5301\/ejo.5000691","article-title":"Ranibizumab versus bevacizumab for the treatment of idiopathic choroidal neovascularization: 2-Year results","volume":"26","author":"Zhou","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111284_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000460496","article-title":"Intravitreal ranibizumab in diabetic macular edema: long-term outcomes","volume":"60","author":"Zucchiatti","year":"2017","journal-title":"Dev. Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526004409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526004409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:45:31Z","timestamp":1793943931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526004409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":25,"alternative-id":["S0014483526004409"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111284","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel laboratory technique for immunofluorescent detection of intraocular ranibizumab in a rat model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111284"}}